Quality of life after colorectal cancer treatment
Quality Of Life In Colorectal Cancer Survivors
This project will test whether late side effects at 6, 12, and 24 months affect quality of life in people aged 25–65 who completed initial treatment for colorectal cancer at the Institute of Oncology Ljubljana.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 368 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institute of Oncology Ljubljana Academic / other |
| Locations | 1 site (Ljubljana) |
| Trial ID | NCT07427901 on ClinicalTrials.gov |
What this trial studies
The study follows colorectal cancer survivors at 6, 12, and 24 months after their first oncological treatment to identify late adverse effects that may influence quality of life. Participants complete validated questionnaires covering physical, psychological, and social well-being, while researchers record diagnosis and specific treatments received. The prevalence of late adverse effects will be measured and analyzed for associations with cancer type and treatment modalities. Findings will be used to map common long-term problems and inform supportive care at the treating institution.
Who should consider this trial
Good fit: Ideal candidates are working-capable adults aged 25–65 with colon or rectal cancer who received their first oncological treatment at the Institute of Oncology Ljubljana and can complete follow-up questionnaires and consent.
Not a fit: People outside the 25–65 age range, those unable to complete questionnaires or attend follow-up visits, and patients treated elsewhere are unlikely to benefit directly from this study.
Why it matters
Potential benefit: If successful, the findings could help clinicians identify and manage late side effects to improve long-term quality of life for colorectal cancer survivors.
How similar studies have performed: Previous follow-up studies have identified common long-term effects after colorectal cancer, so this approach builds on established research while providing local, treatment-specific data.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with colorectal cancer (colon or rectal cancer) * Age 25 to 65 years * First oncological treatment performed at the Institute of Oncology Ljubljana * Working-capable patients * Ability to complete questionnaires * Ability to provide written informed consent Exclusion Criteria: * Age \< 25 years or \> 65 years * Patients unable to complete questionnaires * Patients unable to participate in follow-up assessments * Patients who do not provide written informed consent
Where this trial is running
Ljubljana
- Institute of Oncology Ljubljana — Ljubljana, Slovenia (Recruiting)
Study contacts
- Study coordinator: Klavdija Korošec
- Email: kkorosec@onko-i.si
- Phone: +386 31630065
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.